Skip to main content

Birchview Capital, LP

SEC CIK
0001618205
Latest filing
Aug 14, 2026

URGN holding history

UroGen Pharma Ltd. in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

URGN overviewAll 13F holders of URGNFull Q2 2026 holdings

Shares (Q2 2026)
16,487
Value
$606.7K
% of portfolio
0.3%
Quarters held
1
Since Q2 2026
Holdings of URGN by Birchview Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,487$606.7K0.3%+16,487NewHolders